WASHINGTON–(BUSINESS WIRE)–The Partnership for Safe Medicines (PSM) filed a citizen petition urging the U.S. Food and Drug Administration to block compounding of unapproved peptides and to disregard the advisory committee vote that recommended allowing them, on grounds that the committee was constituted in violation of the Federal Advisory Committee Act (FACA) and the Ethics in Government Act (EIGA), federal laws that govern conflicts of interest in agency advisory proceedings. At a Pharmacy
